Sign inGet started

Main David

Insider CIK 1599941 · AQXP President and CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AQXP AQUINOX PHARMACEUTICALS, I A Award deriv2018-08-072018-08-09415,000— $0415,000SEC↗
AQXP AQUINOX PHARMACEUTICALS, I A Award deriv2018-03-092018-03-13225,000— $0225,000SEC↗
AQXP AQUINOX PHARMACEUTICALS, I M Exercise deriv2017-06-052017-06-053,625— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I S Sale2017-06-052017-06-053,625$13.16 $47.7K71,530SEC↗
AQXP AQUINOX PHARMACEUTICALS, I M Exercise2017-06-052017-06-053,625$9.60 $34.8K75,155SEC↗
AQXP AQUINOX PHARMACEUTICALS, I M Exercise deriv2017-06-022017-06-056,000— $03,625SEC↗
AQXP AQUINOX PHARMACEUTICALS, I S Sale2017-06-022017-06-056,000$13.59 $81.5K71,530SEC↗
AQXP AQUINOX PHARMACEUTICALS, I M Exercise2017-06-022017-06-056,000$9.60 $57.6K77,530SEC↗
AQXP AQUINOX PHARMACEUTICALS, I M Exercise deriv2017-06-012017-06-056,000— $09,625SEC↗
AQXP AQUINOX PHARMACEUTICALS, I S Sale2017-06-012017-06-056,000$13.00 $78.0K71,530SEC↗
AQXP AQUINOX PHARMACEUTICALS, I M Exercise2017-06-012017-06-056,000$9.60 $57.6K77,530SEC↗
AQXP AQUINOX PHARMACEUTICALS, I A Award deriv2017-03-082017-03-10185,000— $0185,000SEC↗
AQXP AQUINOX PHARMACEUTICALS, I A Award deriv2016-03-102016-03-14120,000— $0120,000SEC↗
AQXP AQUINOX PHARMACEUTICALS, I A Award deriv2015-03-122015-03-1665,000— $065,000SEC↗
AQXP AQUINOX PHARMACEUTICALS, I A Award deriv2014-05-082014-05-1265,000— $065,000SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion deriv2014-03-122014-03-1471,530— $00SEC↗
AQXP AQUINOX PHARMACEUTICALS, I D To issuer deriv2014-03-122014-03-149,459$11.00 $104.0K0SEC↗
AQXP AQUINOX PHARMACEUTICALS, I D To issuer2014-03-122014-03-149,459$11.00 $104.0K71,530SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion2014-03-122014-03-1471,530— $071,530SEC↗
AQXP AQUINOX PHARMACEUTICALS, I C Conversion2014-03-122014-03-1471,530— $00SEC↗